Kastelan Darko, Kastelan Marija, Massari Lara Prpic, Korsic Mirko
Division of Endocrinology, Department of Internal Medicine, University Hospital Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.
Med Hypotheses. 2006;67(6):1403-5. doi: 10.1016/j.mehy.2006.04.069. Epub 2006 Jul 17.
Psoriasis is a chronic erythematosquamous disease affecting about 2-3% of the population. It is generally considered to be a T cell-mediated disorder. Psoriasis is characterized by Th1-type cytokine pattern with the predominant secretion of IL-2, IL-6, IFN-gamma and TNF-alpha. Such cytokine pattern is sufficient in inducing keratinocyte hyperproliferation, a hallmark of psoriasis. It seems that development of psoriatic lesions is mediated by TNF-alpha and proliferation of local T cells is dependent on local TNF-alpha production. IL-6 enhances activation, proliferation and chemotaxis of T cells into psoriatic lesions. It is also a direct keratinocyte mitogen that could directly stimulate keratinocyte proliferation. Data of possible association between psoriasis and reduced bone mineral density (BMD) are limited and therefore, not fully conclusive. The major limitation of two studies reported so far was small sample size. Based on increased concentrations of TNF-alpha and IL-6 in psoriasis we hypothesized that these patients are more prone to osteoporosis than healthy subjects. TNF-alpha enhances bone resorption via stimulating osteoclast development and activity as well as bone formation. On the other hand, IL-6 is also a potent stimulator of bone resorption. Moreover, increased production of TNF-alpha and IL-6 has been found in postmenopausal women with osteoporosis. Several lines of evidence support our hypothesis; higher value of IL-6 was recorded in children with idiopathic osteoporosis than in healthy controls; TNF-alpha knock-out mice do not lose bone after ovariectomy; polymorphism of TNFRSF1B gene which encodes 75 Kd TNF receptor is associated with BMD; treatment with anti-TNF-alpha antibody exert beneficial effect on bone metabolism in patients with rheumatoid arthritis and finally, raloxifene inhibit osteoclast activity by reducing TNF-alpha and IL-6 synthesis. However, our hypothesis raised number of questions. Are increased serum concentrations of TNF-alpha and IL-6 mirrored by increased concentrations of these cytokines on the local level? Furthermore, could other cytokines relevant in the pathogenesis of the psoriasis, first of all IFN-gamma, modulate the risk of osteoporosis? Thus, a large prospective, case-control study with the data on BMD, biochemical parameters of bone turnover and fractures have to be done to test our hypothesis.
银屑病是一种慢性红斑鳞屑性疾病,影响约2%-3%的人口。它通常被认为是一种T细胞介导的疾病。银屑病的特征是Th1型细胞因子模式,主要分泌IL-2、IL-6、IFN-γ和TNF-α。这种细胞因子模式足以诱导角质形成细胞过度增殖,这是银屑病的一个标志。银屑病皮损的发展似乎由TNF-α介导,局部T细胞的增殖依赖于局部TNF-α的产生。IL-6增强T细胞向银屑病皮损的激活、增殖和趋化作用。它也是一种直接的角质形成细胞有丝分裂原,可直接刺激角质形成细胞增殖。银屑病与骨密度降低(BMD)之间可能存在关联的数据有限,因此尚未完全定论。迄今为止报道的两项研究的主要局限性是样本量小。基于银屑病中TNF-α和IL-6浓度的升高,我们推测这些患者比健康受试者更容易患骨质疏松症。TNF-α通过刺激破骨细胞的发育和活性以及骨形成来增强骨吸收。另一方面,IL-6也是骨吸收的有效刺激物。此外,在绝经后骨质疏松症女性中发现TNF-α和IL-6的产生增加。几条证据支持我们的假设;特发性骨质疏松症儿童的IL-6值高于健康对照组;TNF-α基因敲除小鼠在卵巢切除术后不会丢失骨质;编码75 Kd TNF受体的TNFRSF1B基因的多态性与骨密度有关;用抗TNF-α抗体治疗对类风湿性关节炎患者的骨代谢有有益作用,最后,雷洛昔芬通过减少TNF-α和IL-6的合成来抑制破骨细胞活性。然而,我们的假设引发了许多问题。血清中TNF-α和IL-6浓度的升高是否反映在局部水平上这些细胞因子浓度的升高?此外,银屑病发病机制中其他相关细胞因子,首先是IFN-γ,是否会调节骨质疏松症的风险?因此,必须进行一项大型前瞻性病例对照研究,收集骨密度、骨转换生化参数和骨折的数据来检验我们的假设。